|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00512 GRAND PHARMA
Nominal 
8.910 +0.010 (+0.112%) | 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | |
| Turnover | 6,107,323 | 0.994% | 6,047,236 | 5,989,486 | 5,212,581 | 4,566,530 |
| Cost of Sales | (2,507,159) | 2.086% | (2,455,927) | (2,121,049) | (1,952,487) | (1,673,689) |
| Gross Profit | 3,600,164 | 0.247% | 3,591,309 | 3,868,437 | 3,260,094 | 2,892,841 |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 174,593 | -60.655% | 443,749 | 170,006 | (392,560) | 298,892 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 57,944 | 207.951% | 18,816 | (6,811) | (48,382) | 23,209 | |
| Profit / (Loss) before Taxation | 1,347,893 | -26.420% | 1,831,882 | 1,325,697 | 915,700 | 1,408,536 | |
| Taxation | (174,023) | -28.730% | (244,175) | (268,926) | (217,777) | (204,299) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (4,851) | -83.701% | (29,762) | (27,417) | 12,488 | (1,694) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 1,169,019 | -24.964% | 1,557,945 | 1,029,354 | 710,411 | 1,202,543 | |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | |
| Net Finance Costs / (Income) | 80,350 | -6.701% | 86,121 | 113,233 | 63,213 | 23,671 |
| Depreciation & Amortisation | 285,424 | 14.555% | 249,159 | 191,555 | 172,539 | 158,302 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | 33.380 | -24.837% | 44.410 | 29.120 | 20.160 | 33.880 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 4.833 | -- | 4.428 | 4.071 | 3.827 | 3.421 |
| Remarks: | Real time quote last updated: 12/09/2025 14:29 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 1,169,019 |
| %Change | -24.964% |
| EPS / (LPS) | HKD 0.334 |
| NBV Per Share ($) | HKD 4.833 |